Radiation Effects on Development of HER2-Positive Breast Carcinomas
暂无分享,去创建一个
S. Ménard | G. Sozzi | T. Camerini | M. Carcangiu | P. Gasparini | E. Tagliabue | T. Triulzi | F. Castiglioni | M. Terenziani | F. Fossati‐Bellani | P. Aiello | L. Bertola | Raffaella Miliano
[1] François Vaillant,et al. Steroid hormone receptor status of mouse mammary stem cells. , 2006, Journal of the National Cancer Institute.
[2] M. Gail,et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. , 2005, Journal of the National Cancer Institute.
[3] J. Benítez,et al. The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications , 2005, Modern Pathology.
[4] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[5] G. Dontu,et al. Breast cancer, stem/progenitor cells and the estrogen receptor , 2004, Trends in Endocrinology & Metabolism.
[6] Alan Ashworth,et al. Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.
[7] G. Dontu,et al. Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.
[8] M. Campiglio,et al. Biologic and therapeutic role of HER2 in cancer , 2003, Oncogene.
[9] F. Berrino,et al. Role of hormonal risk factors in HER2-positive breast carcinomas , 2003, British Journal of Cancer.
[10] C. Benz,et al. Age-associated biomarker profiles of human breast cancer. , 2002, The international journal of biochemistry & cell biology.
[11] I. Weissman,et al. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.
[12] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[13] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[14] P. Goss,et al. Breast cancer risk following irradiation for Hodgkin's disease. , 2000, Cancer treatment reviews.
[15] N. Zeps,et al. Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ERα and ERβ Status , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[16] C. Bartoli,et al. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates , 1999, British Journal of Cancer.
[17] M. Fernö,et al. Correlation between p53, c‐erbB‐2, and topoisomerase IIα expression, DNA ploidy, hormonal receptor status and proliferation in 356 node‐negative breast carcinomas: prognostic implications , 1999, The Journal of pathology.
[18] N. Zeps,et al. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. , 1998, Differentiation; research in biological diversity.
[19] K. Lamborn,et al. Second cancers following pediatric Hodgkin's disease. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] C. Willett,et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease , 1997, Cancer.
[21] E. Klein,et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. , 1997, International journal of radiation oncology, biology, physics.
[22] L. Kalish,et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. , 1996, Blood.
[23] B. Meunier,et al. [Breast cancer after treatment of Hodgkin's disease]. , 1995, Journal de gynecologie, obstetrique et biologie de la reproduction.
[24] C. Land,et al. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. , 1994, Radiation research.
[25] D. Wazer,et al. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. , 1994, Molecular and cellular biology.
[26] M. Tucker,et al. Risk of second cancers after treatment for Hodgkin's disease. , 1988, The New England journal of medicine.
[27] C. Land. Low‐dose radiation–a cause of breast cancer? , 1980, Cancer.
[28] C E Land,et al. Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. , 1980, Journal of the National Cancer Institute.